Skip to main content

PDS Biotechnology Corp

PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472091

No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding PDS Biotechnology Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of PDSB: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders4660+14
Shares6.06M6.78M+720.0K (+11.9%)
Value$74.4M$101.0M+$26.6M (+35.7%)

New holders (19)

Institutions that held PDS Biotechnology Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to PDSB in Q3 2021
InstitutionSharesValue% of portfolio
Two Sigma Advisers, LP478,400$7.13M0.02%
Invesco Ltd.329,698$4.91M0.00%
Fred Alger Management, LLC119,082$1.77M0.00%
Marshall Wace North America L.P.116,677$1.74M0.01%
Marshall Wace, LLP58,173$867.0K0.00%
Trexquant Investment LP42,386$632.0K0.05%
Jump Financial, LLC26,424$393.0K0.03%
Cetera Investment Advisers19,115$285.0K0.00%
Virtu Financial LLC17,696$264.0K0.02%
Jane Street Group, LLC16,739$249.0K0.00%
Total Clarity Wealth Management, Inc.16,642$248.0K0.12%
Commonwealth Equity Services, LLC16,120$240.0K0.00%
Valeo Financial Advisors, LLC15,900$237.0K0.01%
Barclays PLC14,728$219.0K0.00%
Engineers Gate Manager LP13,314$198.0K0.01%
Ground Swell Capital, LLC11,517$172.0K0.74%
Goldman Sachs Group Inc11,395$170.0K0.00%
UBS Group AG2,946$44.0K0.00%
Group One Trading, L.P.200$3.00K0.00%

Sold out (5)

Institutions that held PDS Biotechnology Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of PDSB in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Maven Securities LTD161,305$1.89M
Monashee Investment Management LLC80,000$1.00M
Laurion Capital Management LP62,901$789.0K
683 Capital Management, LLC25,000$314.0K
FMR LLC1$0